Produkty 20402-62-4

CAS 20402-62-4 występuje w naszej ofercie pod nazwami: 10-beta-Hydroxylevonorgestrel, Levonorgestrel Impurity 9（Levonorgestrel EP Impurity I）, 6beta-Deshydroxy-10beta-hydroxylevonorgestrel. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 750mg.

10-beta-Hydroxylevonorgestrel
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Levonorgestrel Impurity 9（Levonorgestrel EP Impurity I）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
6beta-Deshydroxy-10beta-hydroxylevonorgestrel
TRC
  • opakowanie: 750mg
  • Warianty: 1
Zobacz produkt

(8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one (CAS 20402-62-4) to związek chemiczny o wzorze sumarycznym C21H28O3 i masie molowej 328.4 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one. InChIKey: ZMTZYQYDIREIIA-HXIANDDZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H28O3
Masa molowa328.4 g/mol
Nazwa IUPAC(8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
InChIKeyZMTZYQYDIREIIA-HXIANDDZSA-N
SMILESCC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@]34O

Dane obliczone przez PubChem (NCBI)

Synonimy: Levonorgestrel EP Impurity I, 10-Hydroxylevonorgestrel, 10beta-hydroxylevonorgestrel, 10-Hydroxylevonorgestrel [EP], Levonorgestrel impurity I [EP], 10beta-Hydroxy D-(-)-Norgestrel, 13-Ethyl-10,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-10,17-dihydroxy-, (17alpha)-, 6beta-Deshydroxy-10beta-hydroxylevonorgestrel, 10|A-Hydroxy D-(-)-Norgestrel
Powiązane formy tego związku
(8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H28O3
Izomery (ten sam wzór sumaryczny)
methyl (1R,4aS,10aR)-1,4a-dimethyl-9-oxo-7-propan-2-yl-3,4,10,10a-tetrahydro-2H-phenanthrene-1-carboxylate C21H28O3
(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6-dione C21H28O3
methyl (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoate C21H28O3
(8S,10S,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one C21H28O3
(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,6,7,8,9,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C21H28O3
(8S,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,13-dimethyl-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C21H28O3
(6S,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one C21H28O3
(6R,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one C21H28O3
3-hydroxy-2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylcyclohexa-2,5-diene-1,4-dione C21H28O3
(1S,2R,11R,12S,15R,16S)-16-ethyl-15-ethynyl-15-hydroxy-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadecan-5-one C21H28O3
(6S,8R,9S,10R,13S,14S)-6-(methoxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione C21H28O3